user-generated· Science
Will the US FDA approve at least two new GLP-1 receptor agonist drugs…
Market overview
The success of existing GLP-1 drugs like Ozempic and Wegovy, as highlighted by high-profile users like Governor Pritzker, is driving significant pharmaceutical research and development. This increased interest and investment are likely to lead to further innovations and approvals in the GLP-1 class.
Science prediction market
- Implied probability (Yes)
- 60%
- Closes
- 2027-12-31
About this prediction
How this resolves
YES if the U.S. Food and Drug Administration (FDA) grants approval to at least two distinct new GLP-1 receptor agonist drugs for the indication of chronic weight management in adults by December 31, 2027. NO otherwise.
Source: user-generated
More Science markets
- Climate Policy breaks new record this year? — 72% Yes
- Carbon Nanotubes breaks new record this year? — 37% Yes
- Will CRISPR dominate headlines in the next 6-10 months? — 59% Yes
- Major Fusion Energy development by June 2027? — 24% Yes
- Will the total number of elephant deaths officially linked to this specific incident exceed 20 by 2024-10-01? — 0% Yes
- Will the CDC report over 500 confirmed US Cyclospora cases in 2024? — 45% Yes
- Will the UN Secretary-General publicly announce a major new global climate initiative with specific 2030 targets by 2027-09-23? — 60% Yes
- Will Starship achieve a successful orbital flight with payload deployment by June 30, 2025? — 65% Yes
No one's made a Conviction call on this yet. Be the first to call it →
Loading…